Authors:
Haque, T
Taylor, C
Wilkie, GM
Murad, P
Amlot, PL
Beath, S
McKiernan, PJ
Crawford, DH
Citation: T. Haque et al., Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells, TRANSPLANT, 72(8), 2001, pp. 1399-1402
Citation: Sg. Fan et al., Targeting public investments by agro-ecological zone to achieve growth andpoverty alleviation goals in rural India, FOOD POLICY, 25(4), 2000, pp. 411-428
Authors:
Haque, T
Furukawa, T
Takahashi, M
Maeda, K
Kinoshita, M
Citation: T. Haque et al., Myocardial viability detected by dobutamine echocardiography in patients with chronic coronary artery disease, and long-term outcome after coronary angioplasty, JPN CIRC J, 64(3), 2000, pp. 183-190
Authors:
Marcinkeviciene, J
Rogers, MJ
Kopcho, L
Jiang, WJ
Wang, K
Murphy, DJ
Lippy, J
Link, S
Chung, TDY
Hobbs, F
Haque, T
Trainor, GL
Slee, A
Stern, AM
Copeland, RA
Citation: J. Marcinkeviciene et al., Selective inhibition of bacterial dihydroorotate dehydrogenases by thiadiazolidinediones, BIOCH PHARM, 60(3), 2000, pp. 339-342
Authors:
Parry-Jones, N
Haque, T
Ismail, M
Jones, L
Hale, G
Wadmann, H
Gordon-Smith, EC
Crawford, DH
Marsh, JCW
Citation: N. Parry-jones et al., Epstein-Barr virus (EBV) associated B-cell lymphoproliferative disease following HLA identical sibling marrow transplantation for aplastic anaemia ina patient with an EBV seronegative donor, TRANSPLANT, 67(10), 1999, pp. 1373-1375
Citation: T. Haque et Dh. Crawford, The role of adoptive immunotherapy in the prevention and treatment of lymphoproliferative disease following transplantation, BR J HAEM, 106(2), 1999, pp. 309-316
Citation: T. Haque et Dh. Crawford, Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders, SPR SEM IMM, 20(3-4), 1998, pp. 375-387